A Role for ATF2 in Regulating MITF and Melanoma Development

English version České info

The transcription factor ATF2 has been shown to attenuate melanoma susceptibility to apoptosis and to promote its ability to form tumors in xenograft models. To directly assess ATF2's role in melanoma development, we crossed a mouse melanoma model (Nras^Q61K::Ink4a^−/−) with mice expressing a transcriptionally inactive form of ATF2 in melanocytes. In contrast to 7/21 of the Nras^Q61K::Ink4a^−/− mice, only 1/21 mice expressing mutant ATF2 in melanocytes developed melanoma. Gene expression profiling identified higher MITF expression in primary melanocytes expressing transcriptionally inactive ATF2. MITF downregulation by ATF2 was confirmed in the skin of Atf2^−/− mice, in primary human melanocytes, and in 50% of human melanoma cell lines. Inhibition of MITF transcription by MITF was shown to be mediated by ATF2-JunB–dependent suppression of SOX10 transcription. Remarkably, oncogenic BRAF (V600E)–dependent focus formation of melanocytes on soft agar was inhibited by ATF2 knockdown and partially rescued upon shMITF co-expression. On melanoma tissue microarrays, a high nuclear ATF2 to MITF ratio in primary specimens was associated with metastatic disease and poor prognosis. Our findings establish the importance of transcriptionally active ATF2 in melanoma development through fine-tuning of MITF expression.

Vyšlo v časopise: A Role for ATF2 in Regulating MITF and Melanoma Development. PLoS Genet 6(12): e32767. doi:10.1371/journal.pgen.1001258
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001258

Souhrn

Zdroje

1. Gray-SchopferV

WellbrockC

MaraisR

2007 Melanoma biology and new targeted therapy. Nature 445 851 857

2. FearsTR

TuckerMA

2005 Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst 97 1789 1790; author reply 1791

3. ChinL

GarrawayLA

FisherDE

2006 Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 20 2149 2182

4. Lopez-BergamiP

FitchmanB

RonaiZ

2008 Understanding signaling cascades in melanoma. Photochem Photobiol 84 289 306

5. Van RaamsdonkCD

BezrookoveV

GreenG

BauerJ

GauglerL

2009 Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457 599 602

6. LevyC

KhaledM

FisherDE

2006 MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12 406 414

7. BergerAJ

DavisDW

TellezC

PrietoVG

GershenwaldJE

2005 Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction. Cancer Res 65 11185 11192

8. Lopez-BergamiP

HuangC

GoydosJS

YipD

Bar-EliM

2007 Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11 447 460

9. Lopez-BergamiP

LauE

RonaiZ

2010 Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 10 65 76

10. MelnikovaVO

Bar-EliM

2008 Transcriptional control of the melanoma malignant phenotype. Cancer Biol Ther 7 997 1003

11. MitraD

FisherDE

2009 Transcriptional regulation in melanoma. Hematol Oncol Clin North Am 23 447 465, viii

12. Lopez-BergamiP

KimH

DewingA

GoydosJ

AaronsonS

2010 c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis. J Biol Chem 285 903 913

13. RaingeaudJ

WhitmarshAJ

BarrettT

DerijardB

DavisRJ

1996 MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16 1247 1255

14. GuptaS

CampbellD

DerijardB

DavisRJ

1995 Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267 389 393

15. van DamH

WilhelmD

HerrI

SteffenA

HerrlichP

1995 ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14 1798 1811

16. NakamuraT

OkuyamaS

OkamotoS

NakajimaT

SekiyaS

1995 Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site. Exp Cell Res 216 422 430

17. BenbrookDM

JonesNC

1990 Heterodimer formation between CREB and JUN proteins. Oncogene 5 295 302

18. van DamH

CastellazziM

2001 Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20 2453 2464

19. BhoumikA

TakahashiS

BreitweiserW

ShilohY

JonesN

2005 ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol Cell 18 577 587

20. LiS

EzhevskyS

DewingA

CatoMH

ScortegagnaM

2010 Radiation Sensitivity and Tumor Susceptibility in ATM phospho-mutant ATF2 mice. Genes & Cancer in press

21. BergerAJ

KlugerHM

LiN

KielhornE

HalabanR

2003 Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. Cancer Res 63 8103 8107

22. BhoumikA

HuangTG

IvanovV

GangiL

QiaoRF

2002 An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 110 643 650

23. BhoumikA

GangiL

RonaiZ

2004 Inhibition of melanoma growth and metastasis by ATF2-derived peptides. Cancer Res 64 8222 8230

24. BhoumikA

IvanovV

RonaiZ

2001 Activating transcription factor 2-derived peptides alter resistance of human tumor cell lines to ultraviolet irradiation and chemical treatment. Clin Cancer Res 7 331 342

25. BhoumikA

JonesN

RonaiZ

2004 Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity. Proc Natl Acad Sci U S A 101 4222 4227

26. RonaiZ

YangYM

FuchsSY

AdlerV

SardanaM

1998 ATF2 confers radiation resistance to human melanoma cells. Oncogene 16 523 531

27. CheliY

OhannaM

BallottiR

BertolottoC

2010 Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell Melanoma Res 23 27 40

28. HoekKS

SchlegelNC

EichhoffOM

WidmerDS

PraetoriusC

2008 Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 21 665 676

29. MascarenhasJB

LittlejohnEL

WolskyRJ

YoungKP

NelsonM

2010 PAX3 and SOX10 activate MET receptor expression in melanoma. Pigment Cell Melanoma Res

30. YangG

LiY

NishimuraEK

XinH

ZhouA

2008 Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol Cell 32 554 563

31. JacqueminP

LannoyVJ

O'SullivanJ

ReadA

LemaigreFP

2001 The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun 285 1200 1205

32. YasumotoK

TakedaK

SaitoH

WatanabeK

TakahashiK

2002 Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J 21 2703 2714

33. SaitoH

YasumotoK

TakedaK

TakahashiK

FukuzakiA

2002 Melanocyte-specific microphthalmia-associated transcription factor isoform activates its own gene promoter through physical interaction with lymphoid-enhancing factor 1. J Biol Chem 277 28787 28794

34. GoodallJ

CarreiraS

DenatL

KobiD

DavidsonI

2008 Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res 68 7788 7794

35. ThomasAJ

EricksonCA

2009 FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism. Development 136 1849 1858

36. BreitwieserW

LyonsS

FlennikenAM

AshtonG

BruderG

2007 Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev 21 2069 2082

37. BosenbergM

MuthusamyV

CurleyDP

WangZ

HobbsC

2006 Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis 44 262 267

38. SerranoM

LeeH

ChinL

Cordon-CardoC

BeachD

1996 Role of the INK4a locus in tumor suppression and cell mortality. Cell 85 27 37

39. AckermannJ

FrutschiM

KaloulisK

McKeeT

TrumppA

2005 Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res 65 4005 4011

40. SviderskayaEV

HillSP

Evans-WhippTJ

ChinL

OrlowSJ

2002 p16(Ink4a) in melanocyte senescence and differentiation. J Natl Cancer Inst 94 446 454

41. KidoK

SumimotoH

AsadaS

OkadaSM

YaguchiT

2009 Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation. Cancer Sci 100 1863 1869

42. VachtenheimJ

OndrusovaL

BorovanskyJ

2010 SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells. Biochem Biophys Res Commun 392 454 459

43. GodingC

MeyskensFLJr

2006 Microphthalmic-associated transcription factor integrates melanocyte biology and melanoma progression. Clin Cancer Res 12 1069 1073

44. DealKK

CantrellVA

ChandlerRL

SaundersTL

MortlockDP

2006 Distant regulatory elements in a Sox10-beta GEO BAC transgene are required for expression of Sox10 in the enteric nervous system and other neural crest-derived tissues. Dev Dyn 235 1413 1432

45. PoserI

BosserhoffAK

2004 Transcription factors involved in development and progression of malignant melanoma. Histol Histopathol 19 173 188

46. SahaB

SinghSK

SarkarC

BeraR

RathaJ

2006 Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Pigment Cell Res 19 595 605

47. WellbrockC

RanaS

PatersonH

PickersgillH

BrummelkampT

2008 Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS ONE 3 e2734 doi:10.1371/journal.pone.0002734

48. VanceKW

GodingCR

2004 The transcription network regulating melanocyte development and melanoma. Pigment Cell Res 17 318 325

49. GarrawayLA

WidlundHR

RubinMA

GetzG

BergerAJ

2005 Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436 117 122

50. PollockPM

HarperUL

HansenKS

YudtLM

StarkM

2003 High frequency of BRAF mutations in nevi. Nat Genet 33 19 20

51. LinJY

FisherDE

2007 Melanocyte biology and skin pigmentation. Nature 445 843 850

52. WellbrockC

MaraisR

2005 Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. J Cell Biol 170 703 708

53. NoonanFP

RecioJA

TakayamaH

DurayP

AnverMR

2001 Neonatal sunburn and melanoma in mice. Nature 413 271 272

54. FernandezLP

MilneRL

PitaG

FloristanU

SendagortaE

2009 Pigmentation-related genes and their implication in malignant melanoma susceptibility. Exp Dermatol 18 634 642

55. BhoumikA

FichtmanB

DerossiC

BreitwieserW

KlugerHM

2008 Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc Natl Acad Sci U S A 105 1674 1679

56. MaekawaT

ShinagawaT

SanoY

SakumaT

NomuraS

2007 Reduced levels of ATF-2 predispose mice to mammary tumors. Mol Cell Biol 27 1730 1744

57. Gray-SchopferVC

CheongSC

ChongH

ChowJ

MossT

2006 Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 95 496 505

58. HuberWE

PriceER

WidlundHR

DuJ

DavisIJ

2003 A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. J Biol Chem 278 45224 45230

59. BondurandN

PingaultV

GoerichDE

LemortN

SockE

2000 Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet 9 1907 1917

60. CartlidgeRA

ThomasGR

CagnolS

JongKA

MoltonSA

2008 Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival. Pigment Cell Melanoma Res 21 534 544

61. KrajewskaM

SmithLH

RongJ

HuangX

HyerML

2009 Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections. J Histochem Cytochem 57 649 663

62. RuifrokAC

JohnstonDA

2001 Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23 291 299

63. FrankenNA

RodermondHM

StapJ

HavemanJ

van BreeC

2006 Clonogenic assay of cells in vitro. Nat Protoc 1 2315 2319

64. Gould RothbergBE

BergerAJ

MolinaroAM